AU6625701A - Agent for reversal of drug resistance in mycobacterium tuberculosis - Google Patents

Agent for reversal of drug resistance in mycobacterium tuberculosis

Info

Publication number
AU6625701A
AU6625701A AU66257/01A AU6625701A AU6625701A AU 6625701 A AU6625701 A AU 6625701A AU 66257/01 A AU66257/01 A AU 66257/01A AU 6625701 A AU6625701 A AU 6625701A AU 6625701 A AU6625701 A AU 6625701A
Authority
AU
Australia
Prior art keywords
reversal
agent
drug resistance
mycobacterium tuberculosis
mycobacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66257/01A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU6625701A publication Critical patent/AU6625701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU66257/01A 2000-06-28 2001-06-26 Agent for reversal of drug resistance in mycobacterium tuberculosis Abandoned AU6625701A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN597/MUM/2000 2000-06-28
IN597MU2000 2000-06-28
PCT/IB2001/001136 WO2002000165A2 (en) 2000-06-28 2001-06-26 Agent for reversal of drug resistance in mycobacterium tuberculosis

Publications (1)

Publication Number Publication Date
AU6625701A true AU6625701A (en) 2002-01-08

Family

ID=11097261

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66257/01A Abandoned AU6625701A (en) 2000-06-28 2001-06-26 Agent for reversal of drug resistance in mycobacterium tuberculosis

Country Status (4)

Country Link
AP (1) AP2002002454A0 (en)
AU (1) AU6625701A (en)
EA (1) EA004875B1 (en)
WO (1) WO2002000165A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109385439A (en) * 2018-09-18 2019-02-26 上海晶诺生物科技有限公司 The one recombination TM4 phage library and its application for constructing nadh dehydrogenase gene family missing mycobacterium tuberculosis

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040132101A1 (en) 2002-09-27 2004-07-08 Xencor Optimized Fc variants and methods for their generation
EP2345671B8 (en) 2002-09-27 2023-01-11 Xencor, Inc. Optimized fc variants and methods for their generation
EP1610825A2 (en) 2003-03-31 2006-01-04 Xencor, Inc. Methods for rational pegylation of proteins
US7610156B2 (en) 2003-03-31 2009-10-27 Xencor, Inc. Methods for rational pegylation of proteins
US7642340B2 (en) 2003-03-31 2010-01-05 Xencor, Inc. PEGylated TNF-α variant proteins
EP1697741A4 (en) 2003-12-04 2008-02-13 Xencor Inc Methods of generating variant proteins with increased host string content and compositions thereof
EP1737890A2 (en) 2004-03-24 2007-01-03 Xencor, Inc. Immunoglobulin variants outside the fc region
EP2940043A1 (en) 2004-07-15 2015-11-04 Xencor, Inc. Optimized fc variants
KR101027427B1 (en) 2004-11-12 2011-04-11 젠코어 인코포레이티드 Fc VARIANTS WITH INCREASED BINDING TO FcRn
US8802820B2 (en) 2004-11-12 2014-08-12 Xencor, Inc. Fc variants with altered binding to FcRn
AU2008345242B2 (en) 2007-10-31 2014-02-27 Xencor, Inc. Fc variants with altered binding to FcRn
CN101810610B (en) * 2010-04-19 2012-09-26 海南美兰史克制药有限公司 Amoxicillin sodium flucloxacillin sodium medicine compound liposome injection
US9988439B2 (en) 2011-12-23 2018-06-05 Nicholas B. Lydon Immunoglobulins and variants directed against pathogenic microbes
EP2793944A4 (en) 2011-12-23 2015-09-02 Nicholas B Lydon Immunoglobulins and variants directed against pathogenic microbes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633131A (en) * 1992-04-30 1997-05-27 Institut Pasteur Rapid detection of isoniazid resistance in mycobacterium tuberculosis probes for selecting nucleic acid encoding isoniazid resistance, and methods and kits
US5851763A (en) * 1992-09-17 1998-12-22 Institut Pasteur Rapid detection of antibiotic resistance in mycobacterium tuberculosis
US5871912A (en) * 1992-04-30 1999-02-16 Institut Pasteur Nucleic acid probes, sequences and methods for detecting mycobacterium tuberculosis resistant to isoniazid
US5686590A (en) * 1993-05-14 1997-11-11 Agresearch, New Zealand Pastoral Agriculture Research Institute Ltd. Methods and compositions for detecting and treating mycobacterial infections using an INHA gene
ATE261496T1 (en) * 1994-06-09 2004-03-15 Innogenetics Nv METHOD FOR DETECTING THE ANTIBIOTIC RESISTANCE SPECTRUM OF MYCOBACTERIA SPECIES
US6200754B1 (en) * 1998-03-19 2001-03-13 Variagenics, Inc. Inhibitors of alternative alleles of genes encoding products that mediate cell response to environmental changes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109385439A (en) * 2018-09-18 2019-02-26 上海晶诺生物科技有限公司 The one recombination TM4 phage library and its application for constructing nadh dehydrogenase gene family missing mycobacterium tuberculosis

Also Published As

Publication number Publication date
WO2002000165A3 (en) 2002-06-20
EA200200290A1 (en) 2002-12-26
EA004875B1 (en) 2004-08-26
AP2002002454A0 (en) 2002-06-30
WO2002000165A2 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AU2001280188A1 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU2001285020A1 (en) P97-active agent conjugates and their methods of use
AU6625701A (en) Agent for reversal of drug resistance in mycobacterium tuberculosis
AU2001269720A1 (en) Catheter securing device and bite block
AU2002225356A1 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
AU2002241538A1 (en) Intrasvascular drug delivery device and use therefor
AU2001287898A1 (en) Pyrazolopyridines and pyrazolopyridazines as antidiabetics
AU2001257326A1 (en) Topical anesthetic/opioid formulations and uses thereof
HUP0301417A2 (en) Antimikrobal and contraceptive composition and their use
AU2002224324A1 (en) Toilet training article containing an astringent agent
AU2001289308A1 (en) Targeted agents useful for diagnostic and therapeutic applications
AU2002354476A1 (en) Pyrazolopyridine derivatives and medicinal use thereof
GB0101035D0 (en) Formulation and use thereof
AU5073101A (en) Lipid composition and use thereof
AU2003281044A1 (en) Pyrrolopyridine derivative and use thereof
AU2002218502A1 (en) Lactam compounds and medicinal use thereof
AU2002214948A1 (en) Heterocyclylalkyl azole derivatives and use thereof as pesticidal agents
AU2001233176A1 (en) Resistance sequences and uses thereof
AU2001251702A1 (en) Personal drug testing kit
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AUPQ462299A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU4432001A (en) Trityl-type compounds and their use
AU6835300A (en) Diagnostic kit and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase